The largest community of pharma leaders

Cerevance Appoints CNS Drug Developer James Summers, Ph.D. as Scientific Advisor

BOSTON–(BUSINESS WIRE)–<a href=”” target=”_blank”>#CNS</a>–Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, has appointed pharmaceutical industry veteran, James Summers, Ph.D., as a key scientific advisor to guide the company in its drug discovery and development efforts. Dr. Summers brings extensive experience in the discovery of new treatments for Alzheimer’s disease, Parkinson’s disease, pain and psychiatric disorders. Dr. Summers has held a number of leadership positions with…

Recent Articles